Please Wait
Applying Filters...
menu
    • menu
    munit-sa-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Menu

    Tecarfarin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cadrenal Therapeutics Reports Full Year 2024 Results and Business
    Cadrenal Therapeutics Reports Full Year 2024 Results and Business

    13 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250313043048/en/Cadrenal-Therapeutics-Reports-Full-Year-2024-Results-Business-Highlights-and-Path-Forward-for-Clinical-Advancement-of-Tecarfarin

    BUSINESSWIRE
    13 Mar 2025
    Share Share
    Cadrenal, Abbott Partner For Tecarfarin Study In HeartMate 3™ LVAD
    Cadrenal, Abbott Partner For Tecarfarin Study In HeartMate 3™ LVAD

    04 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250304792377/en

    BUSINESSWIRE
    04 Mar 2025
    Share Share
    Cadrenal Therapeutics Reinforces Clinical Plan for Tecarfarin
    Cadrenal Therapeutics Reinforces Clinical Plan for Tecarfarin

    31 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241231455225/en

    BUSINESSWIRE
    31 Dec 2024
    Share Share
    Cadrenal Therapeutics Raises $5.1 Million Via Market Facility
    Cadrenal Therapeutics Raises $5.1 Million Via Market Facility

    24 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cadrenal-therapeutics-raises-5-1-million-via-at-the-market-facility-302285248.html

    PR NEWSWIRE
    24 Oct 2024
    Share Share
    Cadrenal And Abbott Collaborate On Tecarfarin For LVAD Patients
    Cadrenal And Abbott Collaborate On Tecarfarin For LVAD Patients

    06 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cadrenal-therapeutics-and-abbott-initiate-collaborative-effort-to-advance-novel-anticoagulant-tecarfarin-for-patients-with-lvads-302214878.html

    PR NEWSWIRE
    06 Aug 2024
    Share Share
    Cadrenal Engages The Sage Group to Advance Tecarfarin's Late-Stage Development
    Cadrenal Engages The Sage Group to Advance Tecarfarin's Late-Stage Development

    12 Dec 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cadrenal-therapeutics-engages-the-sage-group-to-advance-tecarfarins-late-stage-development-and-commercialization-302012016.html

    PR NEWSWIRE
    12 Dec 2023
    Share Share